Skip to main content
OpenTrials
Completed

NCT Number: NCT05957731

Effect of Agonist Contract Relax Versus Antagonist Contract Relax in Chronic Stroke Patient.

It will be a randomized control trial with 112 patients which will be divided into two groups of 56 patients in each group. Participants will recruit through convenient sampling techniques.

Outcome measures are range of motion and spasticity. The protocol was implemented three days per week for eight consecutive weeks. Data will be collected at baseline and 8 th week after intervention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

40 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

sir Ganga Raam hospital lahore, Lahore, Pakistan

Loading trial locations.

About this study

Objective of the study is to compare the effects of the agonist contract-relax technique versus the antagonist contract-relax technique on spasticity and range of motion in individuals with chronic stroke.

Null hypothesis (H0):

There are no comparative effects of agonist contact-relax technique and the antagonist contract-relax technique on spasticity and ankle range of motion in chronic patients.

The alternate hypothesis (HA):

There are comparative effects of agonist contract-relax technique and the antagonist contract-relax technique on spasticity and ankle range of motion in chronic stroke patients.

The sample size came out to 94 (47 in each group) after adding 20% dropout the sample size was 47+9=56 in each group.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a confirmed diagnosis of stroke by a neurologist.
  • Inclusion of patients with both ischemic and hemorrhagic stroke.
  • Both male and female patients are eligible.
  • Age range between 40 to 60 years.
  • Modified Ashworth Scale ranging from 0 to 2.
  • Minimum muscle strength grade of 3

Exclusion criteria

  • History of surgery on lower limb
  • Who received injection therapies for reducing spasticity
  • Lower extremity contracture
  • Modified Ashworth scale of 3-4

Treatment and study plan

Routine physical therapy

Other

Both groups received routine physical therapy, which encompasses various components such as electrotherapy, strength training for both lower and upper limbs, gait training, and occupational therapy.

antagonist contract relax

Other

antagonist contraction i used to improve spasticity and range of motion in stroke patients

agonist contract relax

Other

agonist contraction is used to improve spasticity and range of motion in stroke patients

Other names: agonist contraction

Primary outcomes

  1. Modified Ashworth Scale.

    Time frame: it will measure change in spasticity at baseline and at 8th week

    The assessment involves extending the limb of the parent from a state of utmost flexion to utmost extension, identifying the point at which initial mild resistance was encountered. Following that, the modified Ashworth Scale is employed while transitioning the limb from extension to flexion. Interrater reliability studies utilizing the MAS have yielded varied results, ranging from moderate to good.

  2. universal goniometer

    Time frame: it will measure change in range of motion at baseline and at 8th week

    The universal goniometer (UG) is a widely employed tool for assessing range of motion.Range of motion refers to the complete extent of movement possible at a specific joint. In a normal ankle, the range of motion typically spans from around 20ºof dorsiflexion to 50º of plantar flexion. For normal walking, a combined motion of approximately 24º to 30º (including both dorsiflexion and plantar flexion) is required.

Sponsors and collaborators

Lead sponsor

University of Lahore

Other

Registry information

Official study title

Effect of Agonist Contract Relax Versus Antagonist Contract Relax Technique on Spasticity and Ankle Range of Motion in Chronic Stroke Patient.

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jul 24, 2023
Registry last updated
Aug 3, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.